Fosfomicin JGL in JGL’s prescription portfolio

At the end of 2017, JGL enriched its prescription portfolio with a new product.

Fosfomicin JGL contains fosfomycin, which is classified as an antibiotic for the treatment of bacterial infections.

The drug is used for the treatment and prevention of acute uncomplicated infections in the lower urinary tract caused by microorganisms susceptible to fosfomycin.

Fosfomicin JGL is intended for the treatment of adults and adolescents above 12 years of age.

To make this website run properly and to improve your experience, we use cookies. For more detailed information, please check our Privacy and personal data protection.

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.